SARS-CoV-2 Nucleocapsid Produkte
(SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte SARS-CoV-2 Nucleocapsid Kategorien
SARS-CoV-2 Nucleocapsid Antikörper
High quality antibodies with extensive validation data.
SARS-CoV-2 Nucleocapsid Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene SARS-CoV-2 Nucleocapsid Antikörper
- (6)
- (3)
- (1)
- (2)
- (3)
- (2)
Empfohlene SARS-CoV-2 Nucleocapsid ELISA Kits
Empfohlene SARS-CoV-2 Nucleocapsid Proteine
- (5)
- (2)
- (1)
- (2)
- (1)
Neueste Publikationen zu unseren SARS-CoV-2 Nucleocapsid Produkten
: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." in: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).
: "Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2. ..." in: Nature communications, Vol. 14, Issue 1, pp. 3583, (2023) (PubMed).
: "Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Issue 30, pp. e2221809120, (2023) (PubMed).
: "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern." in: Journal of dairy science, (2022) (PubMed).
: "Identification of cell type specific ACE2 modifiers by CRISPR screening." in: PLoS pathogens, Vol. 18, Issue 3, pp. e1010377, (2022) (PubMed).
: "The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins." in: Frontiers in bioengineering and biotechnology, Vol. 10, pp. 896751, (2022) (PubMed).
: "Paper-Based Test for Rapid On-Site Screening of SARS-CoV-2 in Clinical Samples." in: Biosensors, Vol. 11, Issue 12, (2022) (PubMed).
: "ARF6 is an important host factor for SARS-CoV-2 infection in vitro." in: bioRxiv : the preprint server for biology, (2022) (PubMed).
: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
Synonyme und alternative Namen zu SARS-CoV-2 Nucleocapsid
nucleocapsid phosphoprotein (N)Haben Sie etwas anderes gesucht?
- SARS-CoV-2 NSP9
- SARS-CoV-2 NSP8
- SARS-CoV-2 NSP7
- SARS-CoV-2 NSP6
- SARS-CoV-2 NSP5 (3CL-Pro)
- SARS-CoV-2 NSP4
- SARS-CoV-2 NSP3
- SARS-CoV-2 NSP2
- SARS-CoV-2 NSP16
- SARS-CoV-2 NSP15
- SARS-CoV-2 NSP14
- SARS-CoV-2 NSP13
- SARS-CoV-2 NSP12 (RdRP)
- SARS-CoV-2 NSP10
- SARS-CoV-2 NSP1
- SARS-CoV-2 Membrane Protein
- SARS-CoV-2 Envelope
- SARS-CoV-2 (CB6 Biosimilar)
- SARS-CoV-2
- SARS-CoV Spike